These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37776214)

  • 1. Long-Term Cumulative High-Sensitivity C-Reactive Protein and Mortality Among Patients With Acute Heart Failure.
    Zhang L; He G; Huo X; Tian A; Ji R; Pu B; Peng Y
    J Am Heart Assoc; 2023 Oct; 12(19):e029386. PubMed ID: 37776214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cumulative high-sensitivity cardiac troponin T and mortality among patients with acute heart failure.
    Zhang L; He G; Huo X; Ji R; Tian A; Pu B; Lei L; Li J; Peng Y
    ESC Heart Fail; 2023 Jun; 10(3):1781-1792. PubMed ID: 36869019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.
    Kalogeropoulos AP; Tang WH; Hsu A; Felker GM; Hernandez AF; Troughton RW; Voors AA; Anker SD; Metra M; McMurray JJ; Massie BM; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Butler J
    J Card Fail; 2014 May; 20(5):319-26. PubMed ID: 24530944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction.
    Lourenço P; Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Leite-Moreira A; Bettencourt P
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):23-29. PubMed ID: 30407267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
    Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
    BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure.
    Santas E; Villar S; Palau P; Llàcer P; de la Espriella R; Miñana G; Lorenzo M; Núñez-Marín G; Górriz JL; Carratalá A; Rodríguez E; Bayes-Genís A; Sanchis J; Núñez J
    Sci Rep; 2024 Sep; 14(1):21672. PubMed ID: 39289385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Elevated C-Reactive Protein Level at Discharge on Long-Term Outcome in Patients Hospitalized for Acute Heart Failure.
    Minami Y; Kajimoto K; Sato N; Hagiwara N;
    Am J Cardiol; 2018 Apr; 121(8):961-968. PubMed ID: 29454477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
    Pellicori P; Zhang J; Cuthbert J; Urbinati A; Shah P; Kazmi S; Clark AL; Cleland JGF
    Cardiovasc Res; 2020 Jan; 116(1):91-100. PubMed ID: 31350553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction.
    Al Aseri ZA; Habib SS; Marzouk A
    Vasc Health Risk Manag; 2019; 15():221-227. PubMed ID: 31410012
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of cumulative health status with subsequent mortality in patients with acute heart failure.
    Peng Y; He G; Wang W; Lei L; Li J; Pu B; Huo X; Yu Y; Zhang L; Li J
    Eur Heart J Qual Care Clin Outcomes; 2024 Mar; ():. PubMed ID: 38449345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.
    Elkind MS; Luna JM; McClure LA; Zhang Y; Coffey CS; Roldan A; Del Brutto OH; Pretell EJ; Pettigrew LC; Meyer BC; Tapia J; White C; Benavente OR;
    Stroke; 2014 Mar; 45(3):707-16. PubMed ID: 24523037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.
    Zhu L; Zou Y; Wang Y; Luo X; Sun K; Wang H; Jia L; Liu Y; Zou J; Yuan Z; Hui R; Kang L; Song L; Wang J
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28154166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
    Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
    Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
    Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
    Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents.
    Choi DH; Park KW; Yang HM; Lee HY; Park JS; Kang HJ; Kim YJ; Koo BK; Oh BH; Park YB; Kim HS
    Int J Cardiol; 2011 Jun; 149(2):174-181. PubMed ID: 20138378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis of patients hospitalized with heart failure and low T
    Zhou P; Huang LY; Zhai M; Huang Y; Zhuang XF; Liu HH; Zhang YH; Zhang J
    Zhonghua Nei Ke Za Zhi; 2023 May; 62(5):526-531. PubMed ID: 37096279
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction.
    Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW
    Can J Cardiol; 2022 Jan; 38(1):92-101. PubMed ID: 34737035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.
    Everett BM; Cornel JH; Lainscak M; Anker SD; Abbate A; Thuren T; Libby P; Glynn RJ; Ridker PM
    Circulation; 2019 Mar; 139(10):1289-1299. PubMed ID: 30586730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.